210 related articles for article (PubMed ID: 28895849)
1. Opening Marrow Niches in Patients Undergoing Autologous Hematopoietic Stem Cell Gene Therapy.
Cowan MJ; Dvorak CC; Long-Boyle J
Hematol Oncol Clin North Am; 2017 Oct; 31(5):809-822. PubMed ID: 28895849
[TBL] [Abstract][Full Text] [Related]
2. [Transplantation of genetically modified cells in the treatment of children with SCID: great hopes and recent disappointments].
Smogorzewska EM; Weinberg KI; Kohn DB
Med Wieku Rozwoj; 2003; 7(1):27-34. PubMed ID: 13130167
[TBL] [Abstract][Full Text] [Related]
3. Gene Therapy Approaches to Hemoglobinopathies.
Ferrari G; Cavazzana M; Mavilio F
Hematol Oncol Clin North Am; 2017 Oct; 31(5):835-852. PubMed ID: 28895851
[TBL] [Abstract][Full Text] [Related]
4. Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning.
Otsu M; Yamada M; Nakajima S; Kida M; Maeyama Y; Hatano N; Toita N; Takezaki S; Okura Y; Kobayashi R; Matsumoto Y; Tatsuzawa O; Tsuchida F; Kato S; Kitagawa M; Mineno J; Hershfield MS; Bali P; Candotti F; Onodera M; Kawamura N; Sakiyama Y; Ariga T
J Clin Immunol; 2015 May; 35(4):384-98. PubMed ID: 25875699
[TBL] [Abstract][Full Text] [Related]
5. Mouse models in hematopoietic stem cell gene therapy and genome editing.
Radtke S; Humbert O; Kiem HP
Biochem Pharmacol; 2020 Apr; 174():113692. PubMed ID: 31705854
[TBL] [Abstract][Full Text] [Related]
6. The Role of Conditioning in Hematopoietic Stem-Cell Gene Therapy.
Bernardo ME; Aiuti A
Hum Gene Ther; 2016 Oct; 27(10):741-748. PubMed ID: 27530055
[TBL] [Abstract][Full Text] [Related]
7. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with CD34+ selected autologous peripheral blood cells transduced with a human ADA gene. Amendment to clinical research project, Project 90-C-195, January 10, 1992.
Blaese RM; Culver KW; Chang L; Anderson WF; Mullen C; Nienhuis A; Carter C; Dunbar C; Leitman S; Berger M
Hum Gene Ther; 1993 Aug; 4(4):521-7. PubMed ID: 7691188
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer into hematopoietic stem cells: prospects for human gene therapy.
Einerhand MP; Valerio D
Curr Top Microbiol Immunol; 1992; 177():217-35. PubMed ID: 1353431
[No Abstract] [Full Text] [Related]
9. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.
Persons DA
Hematology Am Soc Hematol Educ Program; 2009; ():690-7. PubMed ID: 20008255
[TBL] [Abstract][Full Text] [Related]
10. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
Taupin P
IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313
[TBL] [Abstract][Full Text] [Related]
11. Ex Vivo Selection of Transduced Hematopoietic Stem Cells for Gene Therapy of β-Hemoglobinopathies.
Bhukhai K; de Dreuzy E; Giorgi M; Colomb C; Negre O; Denaro M; Gillet-Legrand B; Cheuzeville J; Paulard A; Trebeden-Negre H; Borwornpinyo S; Sii-Felice K; Maouche L; Down JD; Leboulch P; Payen E
Mol Ther; 2018 Feb; 26(2):480-495. PubMed ID: 29221807
[TBL] [Abstract][Full Text] [Related]
12. β3-Adrenoreceptors as ROS Balancer in Hematopoietic Stem Cell Transplantation.
Pasha A; Calvani M; Favre C
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799536
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD117 immunotherapy to eliminate hematopoietic and leukemia stem cells.
Russkamp NF; Myburgh R; Kiefer JD; Neri D; Manz MG
Exp Hematol; 2021 Mar; 95():31-45. PubMed ID: 33484750
[TBL] [Abstract][Full Text] [Related]
14. Gene Therapy Approaches to Immunodeficiency.
Ghosh S; Gaspar HB
Hematol Oncol Clin North Am; 2017 Oct; 31(5):823-834. PubMed ID: 28895850
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy using hematopoietic stem cells.
Kohn DB
Curr Opin Mol Ther; 1999 Aug; 1(4):437-42. PubMed ID: 11713757
[TBL] [Abstract][Full Text] [Related]
16. Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells.
Benjelloun F; Garrigue A; Demerens-de Chappedelaine C; Soulas-Sprauel P; Malassis-Séris M; Stockholm D; Hauer J; Blondeau J; Rivière J; Lim A; Le Lorc'h M; Romana S; Brousse N; Pâques F; Galy A; Charneau P; Fischer A; de Villartay JP; Cavazzana-Calvo M
Mol Ther; 2008 Aug; 16(8):1490-9. PubMed ID: 18560421
[TBL] [Abstract][Full Text] [Related]
17. Transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID.
Bordignon C; Mavilio F; Ferrari G; Servida P; Ugazio AG; Notarangelo LD; Gilboa E; Rossini S; O'Reilly RJ; Smith CA
Hum Gene Ther; 1993 Aug; 4(4):513-20. PubMed ID: 8399494
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for hematopoietic and immune disorders.
Kohn DB
Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S55-8. PubMed ID: 8971410
[TBL] [Abstract][Full Text] [Related]
19. Gene transfer to hematopoietic cells--the clinical experience.
Richter J
Eur J Haematol; 1997 Aug; 59(2):67-75. PubMed ID: 9293853
[No Abstract] [Full Text] [Related]
20. Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.
Punwani D; Kawahara M; Yu J; Sanford U; Roy S; Patel K; Carbonaro DA; Karlen AD; Khan S; Cornetta K; Rothe M; Schambach A; Kohn DB; Malech HL; McIvor RS; Puck JM; Cowan MJ
Hum Gene Ther; 2017 Jan; 28(1):112-124. PubMed ID: 27611239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]